午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Axon Medchem LLC??? ?? ??? ?????.

?? ?:Axon Medchem LLC
??:703 - 9861
???:info@axonmedchem.com
??:United States
URL: www.axonmedchem.com
? ?? ?:763
4 5 6 7 8

?? ????

UNC 06311320288-19-4C37H61N7O2
TMS - Trans-2,3',4,5'-tetramethoxystilbene24144-92-1C18H20O4
Zardaverine?????101975-10-4C12H10F2N2O3
Voriconazole - Vfend | UK 109496?????137234-62-9C16H14F3N5O
UK 383367348622-88-8C15H24N4O4
TMP 195 - TFMO 21314891-22-9C23H19F3N4O3
Tucidinostat - Chidamide | HBI-8000 | CS 055 | Epidaza1616493-44-7C22H19FN4O2
VER 1550085'-O-[(4-?????)??]-8-[[(3,4-??????)??]???]-????1134156-31-2C25H23Cl2N7O4
UNC 02241197196-48-7C26H43N7O2
UNC 06381255580-76-7C30H47N5O2
Trelagliptin succinate - SYR 111472 succinate | SYR 4721029877-94-8C22H26FN5O6
TWS 119601514-19-6C18H14N4O2
Trovafloxacin mesylate - CP 99219 mesylate147059-75-4C21H19F3N4O6S
XMD 8-92 trifluoroacetate1234480-50-2C26H30N6O3
Tubastatin A hydrochloride1310693-92-5C20H22ClN3O2
XL 019945755-56-6C25H28N6O2
XL 3881251156-08-7C23H22FN3O4S
WH-4-023837422-57-8C32H36N6O4
YS 49132836-42-1C20H20BrNO2
UPF 10691048371-03-4C17H13NO3
TTP 22329907-28-0C16H14N2O2S2
VE 8221232416-25-9C24H25N5O3S
UPF 648213400-34-1C11H8Cl2O3
ZL0064-((3,5-????-2-??????)???)-2-???????1181226-02-7C14H11Cl2NO4
URB602565460-15-3C19H21NO2
Y 29794 tosylate143984-17-2C30H42N2O4S3
Zebularine3690-10-6C9H12N2O5
Valdecoxib - SC 65872 | Bextra181695-72-7C16H14N2O3S
U 0126 - U 126109511-58-2C18H16N6S2
VX 680 - MK 0457 | Tozasertib639089-54-6C23H28N8OS
Torin 21223001-51-1C24H15F3N4O
Torin 11222998-36-8C35H28F3N5O2
VE 8211232410-49-9C18H16N4O3S
UNC 06461320288-17-2C36H59N7O2
YMU1902589-96-2C17H22N4O4S
UF 0104-???-N'-?????????537672-41-6C11H15BrN2O
TPI-179756-69-7C12H6Cl2O2
ZT-12-037-012328073-61-4C21H31N5O2
U 73122112648-68-7C29H40N2O3
Y 700 - Piraxostat206884-98-2C16H17N3O3
Wnt-C59 - C591243243-89-1C25H21N3O
USP7-USP47 inhibitor - USP7/47 inhibitor compound 141247825-37-1C18H11Cl2N3O3S3
TM 54411190221-43-2C21H17ClN2O6
Vildagliptin - NVP-LAF 237274901-16-5C17H25N3O2
YK 4-2791037184-44-3C17H13Cl2NO4
Vidofludimus - 4SC-101 | SC 12267717824-30-1C20H18FNO4
VH2982097381-85-4C27H33N5O4S
TMI 005 - Apratastat???????287405-51-0C17H22N2O6S2
XAV 939 - NVP-XAV 939284028-89-3C14H11F3N2OS
UK 356618 - PF 03890101230961-08-7C34H43N3O4
Y 27632 dihydrochloride129830-38-2C14H23Cl2N3O
WP 1130 - Degrasyn856243-80-6C19H18BrN3O
WP 1066857064-38-1C17H14BrN3O
ZCL 278587841-73-4C21H19BrClN5O4S2
ZLN 024723249-01-2C13H13BrN2OS
YUKA1708991-09-7C13H16N4O2S
VX 745209410-46-8C19H9Cl2F2N3OS
Toloxatone - MD 6927629218-27-7C11H13NO3
ZM 447439331771-20-1C29H31N5O4
Tofacitinib citrate - CP 690550-10540737-29-9C16H20N6O.C6H8O7
XL 413 hydrochloride - BMS 863233 hydrochloride1169562-71-3C14H13Cl2N3O2
WZ 40031214265-58-3C25H29ClN6O3
UNC 03791620401-82-2C23H35N5O2
XMD 8-871234480-46-6C24H27N7O2
XL PI3K/mTOR inhibitorXLPI3K/mTOR???934529-30-3C31H29N5O6S
4 5 6 7 8
Copyright 2019 ? ChemicalBook. All rights reserved